Result: In this study, a range of Chinese herbs known for their antitumor or chemotherapy-enhancing properties were evaluated for their ability to inhibit EFHD2 expression in NSCLC cells. This evidence concerns the gene EFHD2 and non-small cell lung carcinoma.